First AD

Second AD

Navigating 2L Treatment Strategies with Oral SERDs and Elasestrant

Video content above is prompted by the following:

What are your perceptions on efficacy and safety data on PROTAC

TACTIVE-K: Phase 1b/2 study of vepdegestrant plus CDK4i PF-07220060

What are your perceptions on efficacy and safety data on SERM:

: Phase 3, ELAINE 3 study of the efficacy and safety of lasofoxifene plus abemaciclib

How do these options compare? Why might you choose one of these options vs fulvestrant?

Clinical

® Clinical Focus page includes a listing of all specialities covered across  OncLive.com, including breast cancer, lung cancer, gastrointestinal cancers, genitourinary cancers, hematologic malignancies, and gynecologic cancers. Each individual specialty page features news articles, interviews in written and video format, and podcasts that focus on unmet needs, treatment advances in both the localized and metastatic settings, and ongoing research.


Breast Cancer

 Breast Cancer condition center page is a comprehensive resource for clinical news and expert insights on various types of breast cancer, including those that are triple negative, hormone receptor positive, and/or HER2 positive. This page features news articles, interviews in written and video format, and podcasts that focus on treatment advances and ongoing research in breast cancer.

OncLive Peer Exchange® 

® Peer Exchange video program comprises lively expert panel discussions feature peer-to-peer exchanges providing authoritative insights, opinions, and perspectives on important issues facing today’s health care professionals. Episodes focus on updates and insights across solid and hematologic malignancies, including breast cancer, lung cancer, gastrointestinal cancers, genitourinary cancers, gynecological cancers, and hematologic malignancies. 

Video Series

Updates in the Treatment of HR+ Breast Cancer  

Peer Exchange

A panel of experts discuss navigating 2L treatment strategies.